Bart G.P. Koot

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability

Non-alcoholic fatty liver disease – A global public health perspective

Human serum albumin: From bench to bedside

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Albumin–drug interaction and its clinical implication

Giardiasis: A review on assemblage distribution and epidemiology in India

Survivors of childhood and adolescent cancer: life-long risks and responsibilities

Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease

A 360-degree overview of paediatric NAFLD: Recent insights

Non-alcoholic fatty liver disease

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Ulcerative colitis

NAFLD: A multisystem disease

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Fecal biomarkers in inflammatory bowel disease: how, when and why?

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions

A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice

População negra e Covid-19: reflexões sobre racismo e saúde

Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review

The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non‐alcoholic fatty liver disease: A randomized controlled trial

Hepatic steatosis in diabetic patients does not predict adverse liver‐related or cardiovascular outcomes

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years

Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: Prevalence and risk factors

Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease

Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement

Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children

Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment

US Cannot Be Used to Predict the Presence or Severity of Hepatic Steatosis in Severely Obese Adolescents

Does Giardia lamblia Cause Villous Atrophy in Children?: A Retrospective Cohort Study of the Histological Abnormalities in Giardiasis

Pediatric NAFLD: an overview and recent developments in diagnostics and treatment

Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

Novel Nonsense Mutation Causes Analbuminemia in a Moroccan Family